Detalles del proyecto
| Estado | Finalizado |
|---|---|
| Fecha de inicio/Fecha fin | 5/27/21 → 2/28/23 |
Financiación
- Integrative Research Laboratories Sweden AB: 28.884,00 US$
IRL790C005: A Randomized, Double-Blind, Placebo-Controlled, Phase IIb Study Evaluating the Efficacy of Mesdopetam on Daily ON-Time Without Troublesome Dyskinesia in Patients with Parkinson#s Disease
- Guduru, Zain (PI)